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ABSTRACT: The effects of aqueous and ethanolic extracts of fenugreek (Trigonella foenum-graecum L.) 
seeds have been studied on the T-47D and ZR-75-1 human breast cancer cell lines. The aqueous fenugreek 
extract was cytotoxic at higher concentrations, while at lower concentrations increased cell viability, 
suggesting the induction of a dose dependent hormetic response in case of both cell lines. The alcoholic 
fenugreek extract was markedly cytotoxic to both breast cancer cell types, and multiple cell division defects 
together with apoptosis were apparent in the affected cells. The viability of breast cancerous cells was 
examined time dependently with the MTT proliferation assay. Both types of the extracts showed significant 
differences in all treatments (P<0.05).  
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INTRODUCTION: 
Breast cancer is one of the most frequently 
diagnosed cancer all over the world, and therefore, 
finding novel remedies that would prevent such a 
disease or increase the efficacy of currently used 
chemo- and radiotherapies are of great importance 
(American Cancer Society, 2016). In this respect, there 
is an ongoing quest across the world for identification 
of natural bioactive compounds or even plant extracts 
with anti-cancer properties (Dietz et al., 2016).  
Fenugreek (Trigonella foenum-graecum) seems to 
be a good source of bioactive compounds with not only 
anti-cancer but several other pharmacological effects 
(Yadav et al., 2014; Moradi and Moradi, 2013; 
Mehrafarin et al., 2010). The analgesic effect of 
fenugreek leaf extracts has been demonstrated on a rats 
using the spinal 5-HT system or purinoceptors 
(Parvizpur et al., 2006; Parvizpur et al., 2004). The 
hepatoprotective activity of fenugreek seed aqueous 
extract and seed specific polyphenol extract have been 
confirmed on rat models (Kumar and Bhandari, 2013; 
Kaviarasan et al., 2008). The hypolipidemic effects of 
fenugreek were studied on animal models, and has 
been found to lower triglycerides, total cholesterol and 
low density lipoprotein levels (Al-Habori and Raman, 
1998; Al-Habori et al., 1998; Petit et al., 1995; Petit et 
al., 1993; Stark and Madar, 1993; Valette et al., 1984). 
The hypolipidemic effects may be due to saponins, a 
class of molecule present in fenugreek that is 
transformed in the gastrointestinal tract to sapogenins. 
Sapogenins increase biliary cholesterol secretion, 
lowering serum cholesterol levels (Sauvaire et al., 
1991; Yoshikawa et al., 1997; Varshney and Sharma, 
1996).  
Hypoglycemic effects have been attributed among 
others to the amino acid 4-hydroxyisoleucine (4-HIL) 
from fenugreek seeds that increases glucose-induced 
insulin release in vitro in human and rat pancreatic islet 
cells (Broca et al., 2004; Sauvaire et al., 1998). In 
addition to stimulating insulin secretion, 4-HIL 
reduced insulin resistance in muscle and/or liver by 
activating insulin receptor substrate-associated 
phosphoinositide 3 (PI3) kinase activity (for review see 
Jetté et al., 2008). Furthermore 4-HIL could inhibit 
palmitate-induced, ROS-associated inflammation and 
restored insulin sensitivity by regulating insulin 
receptor substrate-1 function (Maurya et al., 2014). 
Another in vitro study indicated that fenugreek seed 
extract could phosphorylate a number of proteins, 
including the insulin receptor, insulin receptor 
substrate 1 and p85 subunit of PI3-K, in both 3T3-L1 
adipocytes and human hepatoma HepG2 cells, leading 
to the activation of insulin-signaling pathway in 
adipocytes and liver cells (Vijayakumar et al., 2005).  
It was also shown in insulin resistant HepG2 cells that 
4-HIL did improve insulin resistance by different 
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mechanisms: (i) 4-HIL reduced TNF-α levels by 
affecting the protein expression of the TACE/TIMP3 
(TNF-α converting enzyme/tissue inhibitor of 
metalloproteinase 3) system, and (ii) 4-HIL stimulated 
the expression of insulin receptor substrate-1 (IRS-1) 
and glucose transporter type 4 (GLUT4), (Gao et al., 
2015). In a comparative study using HepG2 cells was 
demonstrated that an aqueous fenugreek seed extract, 
4-HIL and metformin exert similar anti-hyperglycemic 
effects by enhanced insulin signaling, gene expression, 
and increasing glucose uptake (Naicker et al., 2016). 
The anti-inflammatory effects of 4-HIL in TNF-α-
induced insulin resistance in C2C12 myotubes was also 
studied, and showed that 4-HIL reverses the insulin 
resistance by the activation of AMP-activated protein 
kinase (AMPK) and inhibition of suppressor of 
cytokine signaling-3(SOCS-3), (Gautam et al., 2016). 
Besides 4-HL, the diosgenin, a saponin from fenugreek 
was found to induce changes in lipid profile of plasma, 
liver, heart and brain in high-fat diet-streptozotocin 
(HFD-STZ)-induced diabetic rats (Naidu et al., 2015). 
Raju and Bird (2006) demonstrated that oral 
administration fenugreek seeds could alleviate the 
hepatic steatosis by modulation of plasma and liver 
TNF-alpha levels in Zucker obese (fa/fa) rats. 
Moreover, fenugreek reduced insulin resistance by 
increasing the number of insulin receptors in humans 
(Raghuram et al., 1994), adiponectin levels, and 
PPARγ protein expression in rats (Mohammadi et al., 
2016). Another experiment with hydroalcoholic 
fenugreek seed extract increased body weight and 
glucose uptake, reduced plasma glucose, glycosylated 
hemoglobin, liver glucose transport, pro-inflammatory 
cytokines, pancreatic enzymes, and restored depleted 
glycogen in muscle and liver in dose dependent 
manner, including prevention of lipid peroxidation and 
restoration of liver and pancreas GSH and SOD 
activities (Joshi et al., 2015).   
The antioxidant properties of fenugreek seeds were 
suggested to contribute to its health promoting effects 
(for review see Srinivasan, 2014). In an ethanol 
toxicity rat study, an aqueous extract of fenugreek 
seeds prevented the rise in lipid peroxidation and 
enhanced antioxidant potential (Thirunavukkarasu et 
al., 2003). In a CCl4 toxicity rat study, the 
administration of fenugreek seeds and seed extract 
were effective in protecting the liver and kidneys 
through their antioxidant properties by alteration of the 
antioxidant enzyme activities (Mbarki et al., 2017). 
These results are supported by in vitro evidence in 
diabetic human erythrocytes, so that polyphenol acids 
from fenugreek seeds showed a concentration-
dependent inhibition of lipid peroxidation (Kaviarasan 
et al., 2004). Moreover, rat based experimental results 
are suggesting that fenugreek co-administration has a 
powerful antioxidant effect, and might serve as a novel 
and promising preventive strategy against cisplatin-
induced nephron- and hepatotoxicities in some cancer 
therapy (Hegazy et al., 2015). Another study concluded 
that fenugreek seed extract reduced cisplatin induced 
reproductive toxicity in rats by the suppression of 
testicular oxidative stress, apoptosis and inflammations 
(Hamza et al., 2016). Interestingly, a 15-day fenugreek 
seed treatment applied to diabetic rats besides the 
hypoglycemic effect, had improved the altered levels 
of H2O2, MDA, 4HNE, and the activities of SOD, GPx, 
and CAT enzymes by increasing the expression of 
these genes in liver and brain (Sharma et al., 2015). In 
a comparative study, the antioxidant potential of 
fenugreek leaf and seed extracts were evaluated, 
including total phenolics, free radical scavenging 
assay, superoxide anion radical scavenging activity, 
reducing power, lipid peroxidation, ferric thiocyanate 
assay, hydroxyl radical scavenging activity and DNA 
damage protective activities (Singh et al., 2014). 
Results showed that leaf extract had the lowest free 
radical and superoxide anion radical and hydroxyl 
radical scavenging activities with the highest reducing 
power. The leaf extract also showed the maximum 
DNA damage protection activity and higher 
concentration of phytochemicals. However, the seed 
extract showed the maximum inhibition of lipid 
peroxidation. Inclusion of fenugreek seeds in the diet 
of colon carcinogenesis induced rats significantly 
decreased lipid peroxidation with simultaneous 
enhancement of circulating antioxidants like ascorbic 
acid, vitamin E, reduced glutathione, glutathione 
peroxidase, glutathione S-transferase, superoxide 
dismutase and catalase (Devasena and Menon, 2002).  
The above mentioned experiments are strongly 
pinpointing to the anti-cancer effects of fenugreek (for 
review see Jesus et al., 2016; Sung et al., 2012; 
Aggarwal et al., 2008). In case of colon cancer, the 
fenugreek seeds anti-cancer effects were attributed to 
its fiber, flavonoids or saponins that modulated beta-
glucuronidase and mucinase activities (Devasena and 
Menon, 2003). Much of attention was given to 
diosgenin from fenugreek seed since it could suppress 
the colonic aberrant crypt foci formation, and induced 
apoptosis in human colon cancer cells (Raju et al., 
2004). The pure and fenugreek isolated diosgenin 
prevented telomerase activity by down regulating the 
human telomerase reverse transcriptase gene (hTERT) 
gene expression which is critical for telomerase 
activity and the survival of A549 lung cancer cells 
(Rahmati-Yamchi et al., 2014). In case of some human 
breast cancer cell lines, was shown that diosgenin 
inhibited pAkt expression and Akt kinase activity 
without affecting PI3 kinase levels, resulting in the 
inhibition of its downstream targets, NF-kappaB, Bcl-
2, survivin and XIAP (Srinivasan et al., 2009). The 
Raf/MEK/ERK pathway, another functional 
downstream target of Akt, was also inhibited by 
diosgenin in estrogen receptor featuring  (ER+) MCF-7 
cells by causing G1 cell cycle arrest, and down 
regulating cyclin D1, cdk-2 and cdk-4 expression 
leading to the inhibition of cell proliferation and 
induction of apoptosis (Srinivasan et al., 2009). 
Moreover, a chloroform-based fenugreek seed extract 
could effectively reduce the viability of MCF-7 breast 
cancer cells through induction of apoptosis associated 
with increased expression of Caspase 3, 8, 9, p53, Fas, 
FADD, Bax and Bak in a time-and dose-dependent 
manner (Khoja et al., 2011). Cells were exposed to 50 
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μg/mL chloroform-based fenugreek seed extract for 24 
hours, and such a treatment induced apoptosis in 23.2% 
of cells, while a 48-hour exposure caused 73.8% of 
cells to enter apoptosis. In another study, a methanol 
based fenugreek seed extract was assessed on MCF-7 
breast cancer cells, and was found to that at least 90% 
of methanol extract induced apoptosis in breast cell is 
mediated by Fas receptor-independently of either 
FADD, Caspase 8 or 3, as well as p53 interdependently 
(Alshatwi et al., 2013). Furthermore, in case of 
protodioscin, another bioactive compound found in 
fenugreek seeds, was shown to strongly inhibit the  
growth of HL-60 leukemic cells, but had little effect on 
gastric cancer cell line KATO III in vitro (Hibasami et 
al., 2003). Apoptosis in the HL-60 cells might have 
been related to the concentration- and time-dependent 
fragmentation of DNA by protodiosgenin. In case of an 
aqueous fenugreek extract has been found a very 
selective cytotoxicity against cancer cell lines such as 
T-cell lymphoma (TCP), B-cell lymphomas, Thyroid 
Papillary carcinoma (FRO) and breast cancer (MCF7), 
while no significant cell cytotoxicity was detected 
amongst normal cells, including human lymphocytes 
and meningioma (Alsemari et al., 2014). All the above 
mentioned data are clearly indicating that fenugreek 
presents selective cytotoxicity in case of different type 
of cancer cells, and such effects could be triggered by 
different bioactive compounds through several cellular 
mechanisms whose complexity needs further analysis. 
In order to shed light on the fenugreek bioactive 
compound content and the generated anti-cancer 
effects, we carried out the UHPLC-ESI-MS 
characterization of two (aqueous and alcoholic) 
fenugreek seed extracts (Vígh et al., accepted for 
publication). In the current paper we are reporting the 
aqueous and alcoholic extracts effect on human T-47D 
and ZR-75-1 breast cancer cell lines by correlating the 
generated effects with the bioactive compound content 
of the analyzed extracts. 
 
MATERIALS AND METHODS: 
Preparation of plant extracts 
The fenugreek seeds were obtained from 
TRIGONELLA MED. LTD., Mosonmagyaróvár 
(Hungary), and two types of extracts were prepared as 
follows. For the aqueous extract 5g fenugreek dried 
seeds were prepared for 5 min in 100 ml boiling water. 
After cooling at room temperature, the extract was 
centrifuged (10 min, 4000 rpm) and filtered firstly 
through a Whatman filter paper (Sigma Aldrich), and 
stored in refrigerator until administration. The obtained 
samples were stored at 4 °C. For the hydroalcoholic 
extract, 5 g dried fenugreeks seeds were extracted two 
times with 500 ml ethanol –water (1:1) by stirring for 
4hr at 40°C. The obtained fenugreek solutions were 
centrifuged at 4000 rpm for 10 min at room 
temperature, and the ethanol was removed from the 
samples with a rotation vacuum evaporator. The 
obtained samples were stored at 4 °C. The aqueous and 
alcoholic extract samples before being diluted in the 
cell culturing media were filtered through a 0,45 µm 
filter. 
 
Cell culture 
Human breast cancer cell lines T-47D and ZR-75-1 
were obtained from ATCC (American Type Culture 
Collection, USA). These ductal carcinoma cell lines 
were grown in RPMI-1640 (Lonza) culture medium 
supplemented with 1% Antibiotic Antimycotic 
Solution (Invitrogen-Gibco), 10% heat-inactivated FBS 
(Fetal Bovine Serum; Sigma) and 0,1% 1 mM Na-
pyruvate (Biochromag). All cell culture experiments 
were carried out at 37°C in 5% CO2 incubator. 
 
MTT (cytotoxicity) assay 
Cells were used in this studies when 80% 
confluence was reached in T75 flasks (Greiner Bio-
One GmbH). Cells were washed twice with sterile 
PBS, and harvested with Trypsin in the incubator. For 
counting the cells we used Trypan blue dye (Sigma) 
exclusion method and counted with Bürker chamber. 
After it the cells were seeded into 96-well plates at a 
density of 10
4
 cells/well and left to attach to the plates. 
After 24 hours cells were incubated for two and three 
days with various concentrations (10-5-2.5-1.25-0.62-
0.31-0.16-0.08-0.04 v/v%) of extracts. After the 
exposure time removed the extracts and the cells were 
incubated with ten microliter of MTT (5 mg/ml) (3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide) (Sigma) at 37°C for three hours. After 
dissolving the formazan crystals in MTT solution, 
plates were read in a microplate reader (BioTek 
EL808) at 570 nm. This experiment was performed in 
sextuplicates and repeated three times. 
 
Immunostaining and microscopy 
The treatments with both fenugreek extracts were 
carried out in six-well plates and at the examined 
concentration range. At the bottom of each well, a 
coverslip was laid and cells were let to grow on the 
surface of coverslip.  After 2- and 3-day treatments the 
cells were fixed with formaldehyde and stained as 
described by Mathe et al. (2004) and Lemos et al. 
(2000). The microtubules were detected with YL1/2 rat 
monoclonal anti-α-tubulin antibody (Sera Lab, Inc.), 
and POLO like kinase-1 (Plk1) was stained with mouse 
monoclonal Anti-hPlk1 antibody (P5998 Sigma-
Aldrich), while the DNA was counterstained with the 
DAPI dye (Molecular Probes). Digital images of 
optical sections were collected with an Olympus Cell 
R inverted fluorescent microscope system equipped 
with a Hamamatsu CCD camera controlled by the 
Olympus XcellenceR imaging software, using a Plapon 
60x objective. 
 
Statistical analysis 
Statistical analysis were performed by the SPSS 
16.0 software. Statistical differences among treated and 
untreated cells were determined by one-way ANOVA 
(Analysis of Variance). To compare several groups was 
applied the Tukey post-hoc test, and mean differences 
with p< 0.05 were considered statistically significant. 
 
RESULTS AND DISCUSSION: 
We set to analyze the effects of our fenugreek 
extracts on human cancerous breast cells by looking at 
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T-47D and ZR-75-1 cell lines. The T-47D is 
considered a luminal A subtype of breast cancer cell 
line that is endocrine (estrogen receptor expression) 
and often chemotherapy responsive (Holliday and 
Speirs, 2011). The ZR-75-1 is luminal B subtype of 
breast cancer cell line that is usually endocrine 
responsive and shows some kind of variability with 
respect to chemotherapy. The two analyzed cell lines 
are not genetically identical. There have been genomic 
differences detected, ZR-75-1 cells are bearing the 
normal p53 allele, while T-47D cells are featuring a 
mutant allele of p53 gene (Huovinen et al., 2011). The 
ZR-75-1 cells were shown to contain the normal 
BRCA1/2 alleles (Gilardini Montani et al., 2013), 
while in case of T-47D cell line only indirect evidences 
are supporting the presence of normal BRCA1/2 
alleles. It was also demonstrated that the hMAT gene 
expression shows a 10-fold increase in T-47D cells as 
compared to the normal expression levels detected for 
the ZR-75-1 cells (Bandyopadhyay et al., 1996). These 
experimental data are indicating that the T-47D and 
ZR-75-1 cell lines could be considered different 
subtypes of breast cancer, so different we can presume 
some specificity regarding cancer prognosis and 
treatment responses. 
Aqueous fenugreek seed extract generates hormetic 
response in case of treated T-47D cultured cells  
The aqueous fenugreek extract possible effects on 
the viability of T-47D breast cancer cells was tested in 
2 to 3 days long treatments with the culture media 
containing several dilutions of the original extract, and 
for every dilution MTT assays were performed (for 
results see Fig. 1 and 2). Surprisingly, for the 2-day 
treatment experiment, we could observe that in case of 
10 – 0.63% concentration range of aqueous fenugreek 
extract that the treated cancerous cell viability was 
approximately 6 times lower than in case of the control 
untreated cells. We estimate that the hypothetical LD50 
value specific to this extract would fall in between the 
0.31- 0.16% concentration range. Throughout the 0.16 
– 0.04% extract-specific concentration interval, the 
viability of the treated cells was increasing 
progressively, so that at 0.08% and 0.04% 
concentrations the treated cell viability exceeded 
approximately 1.3 times those of the untreated control 
cells. Such a concentration dependent viability-toxicity 
profile was proposed to be specific to hormetic 
responses (Mitchell, 2007; Calabrese and Baldwin, 
2000; Calabrese, 1999; Calabrese and Baldwin, 1999).  
  
 
 
Fig. 1 Cell viability after 2-day treatment using aqueous fenugreek extract. The T-47D cell viability was measured by MTT 
assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line indicates 
the hypothetical LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical 
analysis. Different letters on columns indicate statistical significance at p<0.05. 
 
Looking at the 3-day treatments, in the 10 – 0.31% 
concentration range of aqueous fenugreek extract, the 
viability of treated cancerous cells was 8 times lower, 
yet constant, throughout the assessed concentration 
range as compared to control untreated cells (see 
Fig.2). The 0.16% concentration seems to be close to 
the hypothetical LD50 value in this experiment. Across 
the 0.16 - 0.04% concentration range, the viability of 
treated cells was steadily increasing. At 0.08% extract 
concentrations, the viability of treated cells equaled 
those specific to the control cells, while at 0.04% 
extract concentration the viability of cells surpassed 
showed a 1.2 fold increase as compared to the values 
of untreated control cells. It seems therefore likely that 
the 3-day treatment recapitulates the 2-day experiment, 
and once again the dose dependent hormetic effect was 
evident. 
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Fig. 2 Cell viability after 3-day treatment using aqueous fenugreek extract. The T-47D cell viability was measured by MTT 
assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line indicates 
the LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical analysis. Different 
letters on columns indicate statistical significance at p<0.05. 
 
Alcoholic fenugreek seed extract induces marked 
cytotoxicity on T-47D cultured cells 
We have assessed the alcoholic fenugreek extract 
effect with respect to the viability of T-47D breast 
cancer cells in 2 and 3 days long experiments by 
treating them within culture media containing a 
dilutions of the original extract (for results see Fig. 3 
and 4). In 2-day treatment experiments, we could 
observe that throughout the analyzed concentration 
range the cancerous cell viability was significantly 
reduced. Among the observed values some minimal 
fluctuations were detected. Therefore, the assessed 
concentration range was associated with a 6-12 fold 
decrease of viability in case of treated cells as 
compared to the control cells. No obvious dose 
dependent biphasic effect could be detected suggesting 
that the assessed extract shows a more pronounced 
cytotoxic effect without any indication of hormesis.  
 
 
Fig. 3 Cell viability after 2-day treatment using alcoholic fenugreek extract. The T-47D cell viability was measured by 
MTT assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line 
indicates the LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical analysis. 
Different letters on columns indicate statistical significance at p<0.05. 
 
At the 3-day treatment experiments, we could 
observe that the viability was greatly reduced for 
treated cancerous cells at all concentration assessed 
(see Fig. 4.). The observed significantly low viability 
values showed some but minor degree of variation. 
Accordingly, the viability of treated cells was 
approximately 8-16 times lower as compared to control 
cells. It is also evident that the 3-day long applied 
alcoholic fenugreek extract concentrations are featuring 
a greater level of toxicity than those observed in the 2-
day treatment experiments. Once again no obvious 
signs of hormesis could be detected suggesting that the 
alcoholic fenugreek extract does feature a more 
pronounced cytotoxic effect. 
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Fig. 4 Cell viability after 3-day treatment using alcoholic fenugreek extract. The T-47D cell viability was measured by 
MTT assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line 
indicates the LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical analysis. 
Different letters on columns indicate statistical significance at p<0.05. 
 
Aqueous fenugreek seed extract induces hormetic 
response in case of ZR-75-1 cultured cells 
We have analyzed the aqueous fenugreek seed 
extract effects regarding the viability of ZR-75-1 breast 
cancer cells by carrying out 2 and 3 days long 
treatments within culture media containing different 
dilutions of the original extract (see Fig. 5 and 6). The 
2-day treatment showed that in the 10 – 0.31% 
concentration range of aqueous fenugreek extract the 
treated cancerous cell viability was approximately 3.4 
times lower than in control untreated cells. At the 
0.16% concentration the viability of treated cells seems 
to be close to what one would expect for the LD50 
value in present experiment. Throughout the 0.16 – 
0.04% extract-specific concentration range, the 
viability of the treated cells was increasing, so that at 
0.08% equaled the viability of control untreated cells, 
while at 0.04% concentration, the viability of treated 
cell exceeded 1.2 times the untreated control cells. The 
viability profile of ZR-75-1 cells associated with the 2-
day treatments of aqueous fenugreek seed extract, once 
again recapitulates the hormetic dose response that has 
already been described for the T-47D cells. 
 
 
 
Fig. 5 Cell viability after 2-day treatment using aqueous fenugreek extract. The ZR-75-1 cell viability was measured by 
MTT assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line 
indicates the LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical analysis. 
Different letters on columns indicate statistical significance at p<0.05. 
 
Looking at the 3-day long treatments, at the 10 – 
0.63% concentration interval, the viability of treated 
cancerous cells was markedly reduced, and constant, 
showing at about 8 times lower values as compared to 
control untreated cells (see Fig.  6). The LD50 value is 
expected to fit in between 0.31 - 0.16% concentration 
interval in this experiment. In the 0.31 - 0.04% 
concentration range, the viability of treated cells was 
increasing progressively. At 0.08% extract 
concentration, the viability of treated cells was similar 
to the untreated control cells. However, at 0.04% 
extract concentration, the viability of treated cells 
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surpassed 1.2x the values observed for untreated 
control cells. Therefore, the 3-day treatment seems to 
reiterate the 2-day experiment, and once again a 
hormetic dose response was observed.   
 
 
Fig. 6 Cell viability after 3-day treatment using aqueous fenugreek extract. The ZR-75-1 cell viability was measured by 
MTT assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line 
indicates the LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical analysis. 
Different letters on columns indicate statistical significance at p<0.05. 
 
Alcoholic fenugreek seed extract is associated with a 
strong cytotoxic effect in case of ZR-75-1 cultured 
cells 
We also analyzed the alcoholic fenugreek extract 
ability to influence the viability of ZR-75-1 breast 
cancer cells in 2 to 3 days treatments, while the culture 
media contained different concentrations of the original 
extract (see Fig. 7 and 8). The 2-day treatment 
experiment showed that in the 10 – 0.63% 
concentration interval, the treated cancerous cell 
viability was at least 11 times lower than of untreated 
control cells. Next, in the 0.63-0.08% concentration 
interval, the viability of treated cells increased slightly 
but remained still reduced, being 4.8 times lower than 
the control. However, neither any of the seen viability 
values were close to what would be the hypothetical 
value of LD50. The observed data are strongly 
indicating that the alcoholic fenugreek seed extract is 
featuring a pronounced toxicity in 2-day experiments. 
 
 
Fig. 7 Cell viability after 2-day treatment using alcoholic fenugreek extract. The ZR-75-1 cell viability was measured by 
MTT assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line 
indicates the LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical analysis. 
Different letters on columns indicate statistical significance at p<0.05. 
 
At the 3-day treatment experiments, we could observe 
throughout the analyzed concentration interval that the 
viability was even more pronouncedly reduced in case 
of treated cancerous cells. The observed viability 
values showed some minor variation throughout the 
monitored concentration interval (see Fig.8). The 
viability of treated cells was approximately 20 times 
lower as compared to control cells in the concentration 
interval 10-0.63%. Next, in the concentration interval 
0.31-0.04%, the viability of treated cells was about 9 
times lower than in case of control untreated cells. All 
the observed viability values were very far from the 
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expected LD50 value. It is obvious that the 3-day 
treatment with alcoholic fenugreek extract showed the 
most pronounced toxic effect in case of the ZR-75-1 
cancerous cell line.   
 
 
Fig. 8 Cell viability after 3-day treatment using alcoholic fenugreek extract. The ZR-75-1 cell viability was measured by 
MTT assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line 
indicates the LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical analysis. 
Different letters on columns indicate statistical significance at p<0.05. 
 
Immunostaining reveals multiple cell division 
defects for fenugreek seed extracts treated breast 
cancer cells 
Both fenugreek seed extracts described in current 
paper are affecting the viability of treated human breast 
cancer cell lines. In order to find out how these extracts 
are influencing the treated cells we set to analyze by 
immunostaining their phenotype, hoping that the 
identified defects would reveal details regarding the 
affected cellular phenomena. Such an approach would 
correspond to a phenotypic study, but contrary to a 
classical genetic analysis where mutant alleles 
generated phenotypes are described, in our experiments 
the extracts are responsible for the impeded biological 
phenomenon. Both fenugreek seed extracts are 
affecting the viability of the analyzed cancerous cell 
lines in a dose dependent fashion, and by 
immunostaining we were able to detect multiple 
cellular defects. We could identify cell division defects 
and apoptosis like characteristics. Therefore, we were 
able to detect normal looking interphase and dividing 
cells, together with multi-nucleated presumably 
aneuploid cells, other cells with small or multi-polar 
spindles, and cells showing nuclear blobbing or 
fragmented chromosomes, the latter being specific to 
apoptosis (Fig. 9-10.). We also looked at the structure 
of mitotic spindles, and by monitoring the Polo like 
kinase-1 (Plk1) subcellular localization we taught to 
gain more information about mitotic entry, spindle 
assembly, chromosome alignment, sister chromatid 
segregation, metaphase-anaphase transition and 
cytokinesis. It has been demonstrated that Plk1 
regulates almost every aspect of mitotic events, and its 
overexpression is a marker for poor prognosis in many 
cancers (Weng et al., 2016). In the case of fenugreek 
extracts treated cells we were able to found that Plk–1 
in some instances is associated with centrosomes, 
while in others shows some accumulation along the 
central spindle microtubules of the spindle apparatus 
(Fig. 10.). 
 
 
Fig. 9 Immunostaining of fenugreek extract treated cancer cells.  
Note. A. Untreated cells in interphase together with giant nuclei cells (star) and normal anaphase (arrow). B. Untreated 
cells at interphase (arrowhead) and mitotic metaphase (arrow). C. Extract treated cell with abnormal multipolar spindle 
showing accumulation of chromosomes at spindle poles (arrowhead). D. Extract treated cell showing nuclear blobbing 
and abnormal microtubule network (arrow) as compared to a normal interphase cell (plus).Green indicates microtubules 
and blue shows the chromosome specific DNA. The scale bar represents 20μm. 
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Fig. 10. Immunostaining of fenugreek extract treated cancer cells.  
Note. A. Normal cells in interphase (star) and cytokinesis (arrow). B. cell at mitotic metaphase-anaphase transition with 
centrosomes at spindle poles and PLK associated with centrosomes but not kinetochores (arrow). C. Extract treated cell 
with abnormal bipolar spindle showing normal centrosome at one pole with Plk-1 accumulation (arrow), while the 
opposite pole is much broader with no centrosome (arrowhead) and some PLK accumulation along the spindle 
microtubules (plus). D. Extract treated cell with abnormal monopolar spindle showing PLK accumulation at the spindle 
pole associated centrosome (arrow). Green indicates microtubules, red stands for Plk, and blue shows the chromosome 
specific DNA. The scale bar represents 20μm. 
 
Despite the fact that the performed immunostaining 
revealed certain cellular defects presumably generated 
by the fenugreek extract based treatments, we did not 
carry out a quantitative analysis since after 2- and 3-
day treatments usually the cell number was greatly 
reduced. However, when we looked at the highly 
viable cells coming from the very low concentration 
aqueous fenugreek treatments, we were able to detect 
relatively more normal looking cells, though defects 
were also apparent. To gain a much clearer picture it 
will be necessary to carefully assess the phenotypes all 
treated cells by FACS analyses.  
 
CONCLUSIONS:  
Our studies are indicating specific cell viability 
effects for the aqueous and alcoholic fenugreek seed 
extracts as assessed on the T-47D, ZR-75-1 human 
breast cancer cell lines. In case of aqueous fenugreek 
seed extract, a concentration dependent hormetic 
response was observed, so that at high concentrations 
the extract was cytotoxic, while at lower concentrations 
it increased the treated cell viability, and ultimately at 
the lowest concentrations the viability of the treated 
cancerous cells exceeded at about 1.2 times those of 
control cells (see Table 1). Moreover, the duration of 
aqueous fenugreek extract treatment has also 
influenced the cell viability since the longer, 3-day 
treatments were producing more severe effects as 
compared to shorter 2-day treatments with the 
corresponding extract. It is also interesting to notice 
that the T-47D and ZR-75-1 cells were featuring 
similar concentration- and time-dependent viability 
profiles. Some minor but significant differences 
observed after the 2-day treatment are suggesting that 
the T-47D cells were more responsive to the applied 
aqueous fenugreek seed extract than the ZR-75-1cells.  
 Table 1.  
Concentration dependent variation of T-47D and ZR-75-1 cells’ viability.   
Aqueous fenugreek 
extract treated cells 
2-day treatment 3-day treatment 
conc. range (%) viability conc. range (%) viability 
T-47D 10-0.31 6x↓ 10-0.31 8x↓ 
0.31-0.16 LD50 0.16 LD50 
0.08 1.15x↑ 0.08 1x 
0.04 1.3x↑ 0.04 1.2x↑ 
ZR-75-1 10-0.31 3.4x↓ 10-0.63 8x↓ 
0.16 LD50 0.31-0.16 LD50 
0.08 1x 0.08 1x 
0.04 1.2x↑ 0.04 1.2x↑ 
Note:↑ indicates increased , while ↓ symbolizes decreased cell viability values. 
 
It remains an open question how to explain the 
hormesis specific low dose stimulation and high dose 
inhibition seen in case of the aqueous fenugreek seed 
extract. Similar hormetic dose responses were 
described in numerous studies for chemicals and 
radiation, while for the explanation of the phenomenon 
was evoked the cellular adaptive stress response (for 
review see Calabrese et al., 2012). Hormesis requires a 
different set of interpretations for the dose-specific 
responses. In general terms, at high concentrations 
within the toxicological range, cellular damage will 
occur, while as the concentration falls below the 
threshold, the low concentration specific stimulation 
more likely will represent the manifestation of an 
adaptive stress response facilitated by vitagenes. Genes 
encoding heat shock proteins, heme-oxygenase, 
thioredoxin and glutathione system and sirtuin proteins 
were proposed to act like vitagenes. Such vitagenes 
will activate antioxidant enzymes, chaperons, phase 2 
enzymes, cytoprotective proteins and pathways like 
Keap1/Nrf2/ARE. The emerging picture of hormetic 
low dose stimulatory effect looks rather complicated, 
and requires a system biology type of approach, which 
will be the subject of our future research. Nevertheless
A B C D 
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it seems logic that at lower concentrations, the aqueous 
fenugreek extract composition will change due to the 
dilution of the original stock solution, and these 
concentration differences could elicit different 
biological responses with either deterministic or 
stochastic nature. An aqueous fenugreek extract had 
already been assessed and was found a very selective 
cytotoxicity against certain cancer cell lines such as T-
cell lymphoma (TCP), B-cell lymphomas, Thyroid 
Papillary carcinoma (FRO) and breast cancer (MCF7), 
while no significant cell cytotoxicity was detected 
amongst normal cells, including human lymphocytes 
and meningioma (Alsemari et al., 2014).      
The fact that chemical composition of fenugreek 
seed extracts could be correlated with the induced 
biological effect is further supplemented by our 
experimental results. When the T-47D and ZR-75-1 
cells were treated with alcoholic fenugreek seed 
extracts they were featuring throughout whole 
concentration range and treatment duration markedly 
reduced viability, and no hormetic response was 
evident. It seems likely that the alcoholic extract 
showed a more pronounced cytotoxic effect than the 
aqueous fenugreek seed extract. Indirect 
immunostaining based evidences are indicating that the 
alcoholic fenugreek seed extract could induce 
apoptosis, though multiple mitotic spindle defects were 
also observable even at very low extract concentrations 
(Fig.9-10). When the bioactive compound profile of 
the aqueous and alcoholic fenugreek extracts were 
compared several differences were evident (Vígh et al., 
2017). Bioactive compounds like 4-HIL, asparagine, 
adenine, adenosine, adenosine 3’,5’-cyclic 
monophosphate, cytidine and guanine were identified 
only in the aqueous fenugreek extract. Other 
compounds like aspartic acid, scopoletin, resveratrol, 
naringenin, chrysoeriol, tricin, luteolin-8-C-(2”-O-(E)-
p-coumaroylglycoside), tricin-7-O-glucoside, 
genistein, vitexin, medicarpin, scoparin, 5'-S-Methyl-
5'-thioadenosine, flavin mononucleotide, xanthine, 
soyasaponin I, protoneogitogenin-S5, ursolic acid and 
B3 vitamin were found only in the alcoholic fenugreek 
extract. In case of alcoholic fenugreek extract specific 
naringenin, vitexin and isovitexin it has been shown to 
modulate the SIRT6 in vitro H3K9 deacetylation 
activity, though the exact physiological significance of 
this phenomenon remains obscure (Singh et al., 
2014).The SIRT6 is a master regulator of glucose 
homeostasis by controlling the expression of multiple 
glycolytic genes (Dominy et al., 2012; Liu et al., 
2012;).  What is even more interesting is the fact that 
diosgenin seemed to be present only in the alcoholic 
extract at very low levels, while protodioscin and 
protodiosgenin were absent from both extracts. This it 
means that neither diosgenin nor protodioscin and 
protodiosgenin are responsible for the toxicity of our 
fenugreek seed extracts as it would have been expected 
based on experimental results on MCF-7 human breast 
cancer line (Srinivasan et al.,2009) and HL-60 human 
leukemic cells (Hibasami et al., 2003).  
A comparative study had also shown that the 
aqueous extract had higher antioxidant capacity and 
lower total flavonoid and total phenolic content, while 
the alcoholic extract had lower antioxidant capacity 
and higher total flavonoid and total phenolic contents 
(Vígh et al., 2017, accepted for publication). It remains 
an open question if the different chemical 
compositions, and the aqueous extract higher 
antioxidant capacity or the alcoholic extract total 
flavonoid content could contribute to the differences 
seen in relation to the inhibitory effects on the viability 
of T-47D and ZR-75-1 human breast cancer cell lines. 
However, the fact that 4-HIL is present only in aqueous 
extract and knowing some of its beneficial effects it 
seems worthwhile assessing the putative correlations 
with respect to the increased viability seen at very low 
concentrations. It has been shown that 4-HIL could 
inhibit the secretion of TNFα in 3T3-L1 adipocytes 
(Yu et al., 2013), and reduction of TNFα could 
contribute to the survival of some cancerous cells 
(Aggarwal et al., 2012).    
Future studies of our aqueous and alcoholic 
fenugreek extracts will focus on the assessment of their 
estrogen receptor modulator effect, taking into account 
the fact that estrogenic activity of fenugreek has 
already been reported (Sreeja et al., 2010), while the T-
47D and ZR-75-1 human breast cancer cell lines are 
classified as estrogen receptor (ER) positive, and the 
estrogen receptor was shown to promote the growth of 
breast tumor cells. (Ford et al., 2011). Other plant 
extract based studies carried out on T-47D and ZR-75-
1 cells showed to reduce significantly the mRNA and 
protein levels of estrogen receptor α and such an effect 
could be correlated with activation of proteasomes, and 
inhibition of estrogen-stimulated proliferation (Wang 
et al., 2013).  
Despite the fact that many more papers are 
presenting evidences for the anti-cancer properties of 
fenugreek seeds (Goyal et al., 2016; Chatterjee et al., 
2012; Shabbeer et al., 2009; Sebastian and Thampan, 
2007; Amin et al., 2005), it remains largely 
controversial its beneficial effects since very few 
clinical studies have been reported for fenugreek in the 
treatment of cancers (Swaroop et al., 2015; Alsemari et 
al., 2014), and some genotoxicity has been also 
detected (Ouzir et al., 2016; Flammang et al., 2004). 
Alsemari et al. (2014) are reporting for the first time 
the clinical profile of a human case of primary CNS T 
cell lymphoma that responded to fenugreek treatment 
and resulted in tumor regression, while Swaroop et al. 
(2015) are describing the beneficial effects of 
fenugreek seed extract treatment in case of polycystic 
ovary syndrome. Other clinical studies are indicating 
the beneficial effects of fenugreek based treatments of 
type 2 diabetes patients (Verma et al., 2016), and a 
fenugreek based dietary supplement could improve 
testosterone levels, healthy sperm profile, mental 
alertness, cardiovascular health and overall 
performance in human male subjects (Maheshwari et 
al., 2017). It is also interesting that Assad and Khan 
(2016) demonstrated that fenugreek seeds did not 
reveal any sedative effect but significant antianxiety 
effects were detected. However, consumption of 
fenugreek in humans, rodents, rabbits and chickens 
induced teratogenic effects from congenital 
malformations to death, while in rats, mice and rabbits
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 males testicular toxicity and infertility associated 
oxidative stress and DNA damage were detected 
(Ouzir et al., 2016).   
All together our data are suggesting that the 
aqueous and alcoholic fenugreek seed extracts hold 
promise for consideration in the complementary 
therapy for breast cancer patients. However, further 
studies are needed to carefully assess their potential 
effects before any step is taken regarding their use as 
complementary remedies. In this respect it would be 
important to carefully evaluate all possible anti-cancer, 
anti-diabetic, anti-hypercholesterolemic, anti-
inflammatory properties of our fenugreek extracts since 
results obtained using other fenugreek sources may not 
be totally applicable worldwide. Evidences are 
suggesting that the soil and climatic conditions, the 
applied extraction method could influence the chemical 
composition of fenugreek seeds and consequently their 
health-promoting effects (Alsemari et al., 2014; Vígh 
et al., 2017, accepted for publication).  
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